Skip to main navigation Skip to search Skip to main content

Phosphoproteomics-mediated identification of Fer kinase as a target of mutant Shp2 in Noonan and LEOPARD syndrome

  • Jeroen Paardekooper Overman
  • , Christian Preisinger
  • , Karin Prummel
  • , Monica Bonetti
  • , Piero Giansanti
  • , Albert Heck
  • , Jeroen Den Hertog
  • Royal Netherlands Academy of Arts and Sciences

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Noonan syndrome (NS) and LEOPARD syndrome (LS) cause congenital afflictions such as short stature, hypertelorism and heart defects. More than 50% of NS and almost all of LS cases are caused by activating and inactivating mutations of the phosphatase Shp2, respectively. How these biochemically opposing mutations lead to similar clinical outcomes is not clear. Using zebrafish models of NS and LS and mass spectrometry-based phosphotyrosine proteomics, we identified a downregulated peptide of Fer kinase in both NS and LS. Further investigation showed a role for Fer during development, where morpholino-based knockdown caused craniofacial defects, heart edema and short stature. During gastrulation, loss of Fer caused convergence and extension defects without affecting cell fate. Moreover, Fer knockdown cooperated with NS and LS, but not wild type Shp2 to induce developmental defects, suggesting a role for Fer in the pathogenesis of both NS and LS.

Original languageEnglish
Article numbere106682
JournalPLoS One
Volume9
Issue number9
DOIs
Publication statusPublished - 3 Sept 2014

Bibliographical note

Publisher Copyright:
© 2014 Paardekooper Overman et al.

Fingerprint

Dive into the research topics of 'Phosphoproteomics-mediated identification of Fer kinase as a target of mutant Shp2 in Noonan and LEOPARD syndrome'. Together they form a unique fingerprint.

Cite this